The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assuring dietary supplement quality for cancer patients: An integrated formulary systems approach.
Maurie Markman
Consultant or Advisory Role - Amgen; BIND Biosciences; Boehringer Ingelheim; Celgene; Eisai; Genentech; Hana BioSciences
Michael Levin
Consultant or Advisory Role - Cancer Treatment Centers of America; Flora Research (U); KML Labs (U); Thorne Research
Paul Reilly
No relevant relationships to disclose
Joseph W. Coyne
No relevant relationships to disclose
Carolyn Lammersfeld
No relevant relationships to disclose
Timothy C. Birdsall
No relevant relationships to disclose